These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12811109)

  • 1. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly.
    Liu SZ; Romeis JC
    Med Care; 2003 Dec; 41(12):1331-42. PubMed ID: 14668666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More of the same is not enough.
    Willison DJ
    Healthc Pap; 2002; 3(1):47-55; discussion 87-94. PubMed ID: 12811111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of drug prescription monitoring systems in the extra-hospital environment.
    Lucioni C; Rossi F
    Ann Ist Super Sanita; 1991; 27(2):225-33. PubMed ID: 1755575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug utilization decisions should be based on cost-benefit data].
    Bengt J; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Apr 18-24; 102(16):1264-5; discussion 1265. PubMed ID: 15921102
    [No Abstract]   [Full Text] [Related]  

  • 8. Information systems for the analysis of drug prescriptions in Spain.
    Ferrando MC
    Ann Ist Super Sanita; 1991; 27(2):213-6. PubMed ID: 1755573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variability in prescription drug utilization: issues for research.
    Anis AH; Carruthers SG; Carter AO; Kierulf J
    CMAJ; 1996 Mar; 154(5):635-40. PubMed ID: 8603319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible applications of drug prescription monitoring systems in Italy.
    Bozzini L
    Ann Ist Super Sanita; 1991; 27(2):207-11. PubMed ID: 1755572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug policy: making effective drugs available without bankrupting the healthcare system.
    Laupacis A; Anderson G; O'Brien B
    Healthc Pap; 2002; 3(1):12-30. PubMed ID: 12811107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
    Liu SZ; Romeis JC
    Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managing healthcare costs within an integrated framework.
    Fernandes R
    Healthc Pap; 2002; 3(1):70-6; discussion 87-94. PubMed ID: 12811114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality reports reduce drug costs in primary health care. Stockholm County Council a model for decentralized expenditure responsibility].
    Almkvist H; Bergman U; Edlert M; Juhasz-Haverinen M; Pehrsson A; Bergen-Dahl GT; Veg A; Wettermark B
    Lakartidningen; 2008 Oct 15-21; 105(42):2930-4. PubMed ID: 19025150
    [No Abstract]   [Full Text] [Related]  

  • 16. The Common Drug Review: a NICE start for Canada?
    McMahon M; Morgan S; Mitton C
    Health Policy; 2006 Aug; 77(3):339-51. PubMed ID: 16214257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Let evidence be the arbiter.
    Lindberg MC
    Healthc Pap; 2002; 3(1):43-6; discussion 87-94. PubMed ID: 12811110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Family physicians resist high prescription risk].
    Schmidt K
    MMW Fortschr Med; 2003 May; 145(20):58. PubMed ID: 12822233
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug policy: an oxymoron?
    Gray J
    Healthc Pap; 2002; 3(1):56-62; discussion 87-94. PubMed ID: 12811112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia.
    Morgan SG; Agnew JD; Barer ML
    Health Policy; 2004 Jun; 68(3):299-307. PubMed ID: 15113641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.